OCUPHIRE PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.64 USD | +3.47% |
|
+7.19% | -45.51% |
| Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
| Apr. 11 | Ocuphire Pharma, Inc. Announces Global License Agreement with Viatris Inc | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.890 | 2.230 | 2.630 |
| Spread/Res. | -13.23% | -26.46% | -37.64% |
| Spread/Supp. | +8.61% | +8.61% | +1.86% |
| Support | 1.510 | 1.510 | 1.610 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- OCUP Stock
- Charts Ocuphire Pharma, Inc.
